SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-001587
Filing Date
2023-01-30
Accepted
2023-01-30 16:45:07
Documents
1
Period of Report
2023-01-26

Document Format Files

Seq Description Document Type Size
1 form4-01302023_090159.html 4  
1 form4-01302023_090159.xml 4 5991
  Complete submission text file 0001415889-23-001587.txt   7535
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Braunstein Scott (Reporting) CIK: 0001643875 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 23568482